Bioactive compounds and probiotics–a ray of hope in COVID-19 management

The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti-viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhushan, Indu, Sharma, Mahima, Mehta, Malvika, Badyal, Shivi, Sharma, Varun, Sharma, Indu, Singh, Hemender, Sistla, Srinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982983/
http://dx.doi.org/10.1016/j.fshw.2021.02.001
_version_ 1783667833953058816
author Bhushan, Indu
Sharma, Mahima
Mehta, Malvika
Badyal, Shivi
Sharma, Varun
Sharma, Indu
Singh, Hemender
Sistla, Srinivas
author_facet Bhushan, Indu
Sharma, Mahima
Mehta, Malvika
Badyal, Shivi
Sharma, Varun
Sharma, Indu
Singh, Hemender
Sistla, Srinivas
author_sort Bhushan, Indu
collection PubMed
description The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti-viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance immunity. This review highlights some of the important bioactive compounds and probiotic bacteria, suggesting them as a ray of hope in the milieu of the COVID-19 management.
format Online
Article
Text
id pubmed-7982983
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-79829832021-03-23 Bioactive compounds and probiotics–a ray of hope in COVID-19 management Bhushan, Indu Sharma, Mahima Mehta, Malvika Badyal, Shivi Sharma, Varun Sharma, Indu Singh, Hemender Sistla, Srinivas Food Science and Human Wellness Article The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti-viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance immunity. This review highlights some of the important bioactive compounds and probiotic bacteria, suggesting them as a ray of hope in the milieu of the COVID-19 management. 2021-03 2021-03-22 /pmc/articles/PMC7982983/ http://dx.doi.org/10.1016/j.fshw.2021.02.001 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bhushan, Indu
Sharma, Mahima
Mehta, Malvika
Badyal, Shivi
Sharma, Varun
Sharma, Indu
Singh, Hemender
Sistla, Srinivas
Bioactive compounds and probiotics–a ray of hope in COVID-19 management
title Bioactive compounds and probiotics–a ray of hope in COVID-19 management
title_full Bioactive compounds and probiotics–a ray of hope in COVID-19 management
title_fullStr Bioactive compounds and probiotics–a ray of hope in COVID-19 management
title_full_unstemmed Bioactive compounds and probiotics–a ray of hope in COVID-19 management
title_short Bioactive compounds and probiotics–a ray of hope in COVID-19 management
title_sort bioactive compounds and probiotics–a ray of hope in covid-19 management
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982983/
http://dx.doi.org/10.1016/j.fshw.2021.02.001
work_keys_str_mv AT bhushanindu bioactivecompoundsandprobioticsarayofhopeincovid19management
AT sharmamahima bioactivecompoundsandprobioticsarayofhopeincovid19management
AT mehtamalvika bioactivecompoundsandprobioticsarayofhopeincovid19management
AT badyalshivi bioactivecompoundsandprobioticsarayofhopeincovid19management
AT sharmavarun bioactivecompoundsandprobioticsarayofhopeincovid19management
AT sharmaindu bioactivecompoundsandprobioticsarayofhopeincovid19management
AT singhhemender bioactivecompoundsandprobioticsarayofhopeincovid19management
AT sistlasrinivas bioactivecompoundsandprobioticsarayofhopeincovid19management

Ejemplares similares